Kozak et al. [41] identified by micro-LC-MS/MS four biomarkers for early stage ovarian cancer (transthyretin, apolipoprotein A1, transferrin, and beta-hemoglobin), corresponding to already described 13.9-TTR-, 12.9-TTR-, 15.9-Hb-, 28-ApoAI-, 79-Tf-kDa SELDI peaks [68]. This evidence concerns the gene TF and ovarian cancer.